The gut metabolite 3-hydroxyphenylacetic acid rejuvenates spermatogenic dysfunction in aged mice through

Zirun Jin1,2,3,4, Yuzhuo Yang5, Yalei Cao1

  • 1Department of Urology, Center for Reproductive Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.

Microbiome
|September 26, 2023
PubMed
Abstract

Insights

Gut bacteria metabolite 3-hydroxyphenylacetic acid (3-HPAA) can reverse age-related male fertility decline. This metabolite improves sperm quality by regulating ferroptosis, offering potential therapeutic applications for aging males.

Area of Science:

  • Reproductive biology
  • Microbiome research
  • Aging studies

Background:

  • Male reproductive aging is characterized by decreased sperm quality and fertility.
  • The gut microbiome's role in male reproductive aging remains largely unexplored.
  • Aging alters intestinal physiology and gut microbiota composition.

Discussion:

  • Fecal microbiota transplantation (FMT) between young and old mice revealed a key gut bacteria-derived metabolite.
  • 3-hydroxyphenylacetic acid (3-HPAA) was identified as a crucial factor influencing spermatogenesis.
  • The study investigated the mechanism by which 3-HPAA impacts male fertility.

Key Insights:

  • FMT from young to old mice alleviated aging-associated spermatogenic dysfunction.
  • 3-HPAA treatment improved spermatogenesis in aged mice.
  • 3-HPAA upregulates GPX4, inhibiting ferroptosis and restoring sperm production.

Outlook:

  • 3-HPAA represents a novel therapeutic target for age-related male infertility.
  • This research provides a new understanding of dysregulated spermatogenesis in aging males.
  • Further clinical studies are warranted to explore 3-HPAA's therapeutic potential.